已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
超级安阳完成签到 ,获得积分10
2秒前
2秒前
4秒前
jjiiii发布了新的文献求助10
5秒前
帅气的Taq酶完成签到 ,获得积分10
5秒前
糖丸完成签到,获得积分10
6秒前
桐桐应助个性冰绿采纳,获得10
7秒前
宋笨笨发布了新的文献求助10
7秒前
小马不叫宝莉完成签到,获得积分10
7秒前
苏容完成签到 ,获得积分10
8秒前
娟娟完成签到,获得积分10
8秒前
10秒前
tangli完成签到 ,获得积分10
10秒前
10秒前
马佳音完成签到 ,获得积分10
10秒前
10秒前
笑点低的悒完成签到 ,获得积分10
10秒前
zheng发布了新的文献求助30
10秒前
嵩嵩常安完成签到 ,获得积分10
12秒前
13秒前
呀呀呀完成签到,获得积分10
13秒前
陈陈完成签到,获得积分10
17秒前
hubo完成签到,获得积分10
18秒前
谢谢谢发布了新的文献求助10
18秒前
HSJ完成签到 ,获得积分10
19秒前
19秒前
爱吃辣条发布了新的文献求助10
20秒前
20秒前
star完成签到,获得积分10
21秒前
陈陈发布了新的文献求助10
22秒前
Lemon发布了新的文献求助10
24秒前
28秒前
呀呀呀发布了新的文献求助10
30秒前
33秒前
啵啵发布了新的文献求助10
33秒前
885791403完成签到 ,获得积分10
35秒前
谢谢谢发布了新的文献求助10
37秒前
默默小馒头完成签到 ,获得积分10
38秒前
38秒前
39秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6944883
求助须知:如何正确求助?哪些是违规求助? 8630248
关于积分的说明 18306049
捐赠科研通 6380455
什么是DOI,文献DOI怎么找? 3079518
关于科研通互助平台的介绍 2120677
邀请新用户注册赠送积分活动 2056385